United Kingdom· GB-APID-12612711000001106
Isoniazid 130mg/5ml oral solution
A isoniazid product containing isoniazid, registered in United Kingdom by Special Order. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Isoniazid is registered in 15 of 19 countries.
Countries holding a registration under ATC J04AC01 (isoniazid), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Isoniazid · ATC J04AC01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of isoniazid costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $1.15 in France to $4.87 in Switzerland — a ×4.3 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Isoniazid · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.87
- FR France$1.15
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Isoniazid
- Manufacturer
- Special Order
- Country
- United Kingdom (GB)
- ATC code
- J04AC01
- ATC class
- Isoniazid
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for isoniazid.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Isoniazid · interactions on record
335 records
- 5 severe
- 233 moderate
- 26 minor
- 67 info
Most severe, free to view
- AlosetronA03AE01moderate
- Sodium picosulfateA06AB08moderate
- BudesonideA07EA06moderate
- LiraglutidA08AX02moderate
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Isoniazid in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesisoniazidMarlex Pharmaceuticals, Inc.
- Japanイソニアジド
- NorwayIsoniazid SASykehusapotekene HF
- FranceRIMIFON 150 mg, compriméPHARMHOLDING (LUXEMBOURG)
- CanadaPDP-ISONIAZIDPENDOPHARM DIVISION OF PHARMASCIENCE INC
- CzechiaISONIAZID
- GermanyIsozidEsteve Pharmaceuticals Gmbh
- SwitzerlandIsoniaz-TB
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Inh Agepha
- Belgium · Nicotibine
- Bulgaria · Изонид, Изонид Дансон-Бг
- Czechia · Nidrazid
- Germany · Isozid, Isozid N
- Denmark · Isoniazid Oba
- Spain · Cemidon
- Finland · Tubilysin
- France · Rimifon
- Greece · Dianicotyl
- Hungary · Isonicid
- Iceland · Tibinide
- Italy · Nicozid
- Luxembourg · Nicotibine
- Netherlands · Isoniazide Costero
- Poland · Nidrazid
- Portugal · Isoniazida Labesfal
- Romania · Izoniazidă Arena, Izoniazida Atb
- Sweden · Tibinide
- Slovakia · Nidrazid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ee40eed0-6b47-41e8-b055-3d5d29fef40e GET /v1/drugs/ee40eed0-6b47-41e8-b055-3d5d29fef40e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "12612711000001106",
"desc": "Isoniazid 130mg/5ml oral solution (Special Order)",
"form": "Oral solution",
"vpid": "12640111000001103",
"source": "dmd",
"vtm_id": "776412002",
"strength": "26 mg",
"substance": "Isoniazid",
"ingredient": "Isoniazid",
"supplier_code": "8286711000001104"
}See everything about isoniazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.